Bionoid Pharma (Bionoid Pharma) Liabilities-to-Assets : 3.29 (As of Mar. 2011)

Bionoid Pharma Liabilities-to-Assets Chart

Bionoid Pharma Quarterly Data
	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
Liabilities-to-Assets	Get a 7-Day Free Trial												6.11	4.85	4.90	1.66	3.29

Competitive Comparison of Bionoid Pharma's Liabilities-to-Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Bionoid Pharma's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bionoid Pharma's Liabilities-to-Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bionoid Pharma's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Bionoid Pharma's Liabilities-to-Assets falls into.

Bionoid Pharma Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Bionoid Pharma's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2010 is calculated as:

Bionoid Pharma's Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2011 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionoid Pharma  (OTCPK:BINP) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.

Bionoid Pharma Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Bionoid Pharma's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Bionoid Pharma (Bionoid Pharma) Business Description